September 15, 2023
Will The Trump Administration Turn Back Federal Vaping Laws?
- Last Updated: July 27th, 2023
Will The Trump Administration Turn Back Federal Vaping Laws?
Donald Trump’s unexpected election in November and his pledge to reduce federal regulations on businesses have given the e-cigarette industry hope that the new administration will favor rolling back vaping laws and regulations on the devices, erasing all the huge strides made recently by U.S. Surgeon General Dr. Vivek Murthy.
In a report released to the public on December 8, 2016, Surgeon General Murthy called e-cigarettes an “emerging public health threat” for young people.
Shortly thereafter, the surgeon general created a website to make sure teens “Know the Risks of E-Cigarettes & Young People.”
Besides explaining the basics of what an “e-cig” is, the Surgeon General warns teens about the use of “flavorants such as diacetyl, a chemical linked to serious lung disease” on the website.
The role of Surgeon General is a position appointed by the President.
In 2010, the Affordable Care Act expanded the role of Surgeon General to also act as the Chair of the National Prevention Council, which provides coordination and leadership among 20 executive departments with respect to prevention, wellness, and health promotion activities.
President Trump has not yet appointed his Surgeon General, but he has now signed a repeal of the Affordable Care Act which may limit the role of the Surgeon General.
This repeal and the promise of reducing federal regulations by President Trump has given hope to the tobacco lobby groups who want to delay implementation of the new rules in the short term and repeal the 2016 law that treats electronic nicotine delivery systems (ENDS) like cigarettes in the long-term.
Table of Contents
Tobacco Product Regulation
In 2009, Congress gave the U.S. Food and Drug Administration (FDA) the authority to oversee all tobacco products, and the Tobacco Control Act that took effect in August 2016 brought e-cigarettes, cigars, pipe tobacco, and hookah tobacco under existing rules that regulate cigarettes and smokeless tobacco.
These rules require companies to:
- Submit e-cigarettes and tobacco products introduced after February 2007 to the government for approval
- List Electronic Nicontine Delivery Systems (ENDS) ingredients
- Include health warnings on labels and in marketing materials
While health advocacy groups strongly favored the new rules because the potential health risks of e-cigarettes are still being studied, industry officials insisted that they would hurt small companies and stall business development.
Diacetyl lawsuits involving individuals harmed while working with flavorants made from Diacetyl continue to be filed and only time will tell if E-cigarette users who are heating flavorants containing diacetyl end up with similar serious lung diseases.
Written By:
Jessie Paluch
Experienced Attorney & Legal SaaS CEO
With over 25 years of legal experience, Jessie is an Illinois lawyer, a CPA, and a mother of three. She spent the first decade of her career working as an international tax attorney at Deloitte.
In 2009, Jessie co-founded her own law firm with her husband – which has scaled to over 30 employees since its conception.
In 2016, Jessie founded TruLaw, which allows her to collaborate with attorneys and legal experts across the United States on a daily basis. This hypervaluable network of experts is what enables her to share reliable legal information with her readers!
Do You
Have A Case?
Here, at TruLaw, we’re committed to helping victims get the justice they deserve.
Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?
About TruLaw
At TruLaw, we fiercely combat corporations that endanger individuals’ well-being. If you’ve suffered injuries and believe these well-funded entities should be held accountable, we’re here for you.
With TruLaw, you gain access to successful and seasoned lawyers who maximize your chances of success. Our lawyers invest in you—they do not receive a dime until your lawsuit reaches a successful resolution!
Do you believe you’re entitled to compensation?
Use our Instant Case Evaluator to find out in as little as 60 seconds!
Camp Lejeune Lawsuit
Tylenol Lawsuit
AFFF Lawsuit
Camp Lejeune Lawsuit
Camp Lejeune Lawsuit
Camp Lejeune’s water contamination issue spanned several decades starting in the 1950s. Exposure to these chemicals has been linked to various serious health issues, including cancer, organ diseases, and death.
Tylenol Lawsuit
Tylenol Lawsuit
Research is increasingly suggesting a link between the use of Tylenol during pregnancy and the development of neurodevelopmental disorders, such as autism and ADHD, in infants.
AFFF Lawsuit
AFFF Lawsuit
Legal action is being taken against manufacturers of Aqueous Film-Forming Foam (AFFF), a chemical used in fighting fires. The plaintiffs allege that exposure to the foam caused health issues such as cancer, organ damage, and birth and fertility issues.
Recent Posts
Do You
Have A Case?
Here, at TruLaw, we’re committed to helping victims get the justice they deserve.
Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?
Related Articles
FDA warns – Weis Quality Brownie Moose Tracks Ice Cream, 48oz recalled due to undeclared egg
Weis Market Inc., a Mid-Atlantic food retailer based in Sunbury, Pennsylvania, has recalled its 48-ounce containers of Weis Quality Brownie Moose Tracks Ice Cream because the product may contain traces of egg, an allergen not declared on the ingredient statement label, according to the FDA.
September 15, 2023
FDA warns – Single lot of Digoxin Tablets USP in 0.125mg, 0.25mg recalled due to swapped labels
Marlex Pharmaceuticals, Inc., of New Castle, Delaware, has announced a voluntary, consumer-level recall of one lot of Digoxin Tablets USP, 0125mg, as well as one lot of Digoxin Tablets USP, 0.25mg, because the labels of both products have been mixed up, according to the FDA.
September 14, 2023